OppenheimerFunds’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
OppenheimerFunds's LLY Position: Q1 2019 in Review
OppenheimerFunds increased its Eli Lilly (LLY) stake by 336% in Q1 2019, buying an estimated $8.29M and bringing the position to 88,460 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #652.
OppenheimerFunds first reported a position in LLY in Q4 2014 and has held it in 18 quarters since. The position peaked at $60.1M in Q3 2015. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.
- OppenheimerFunds held 88,460 shares of Eli Lilly worth $11.5M as of Q1 2019.
- OppenheimerFunds bought 68,180 Eli Lilly shares in Q1 2019, an estimated $8.29M.
- Eli Lilly made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #652 holding.
- OppenheimerFunds first reported a position in Eli Lilly in Q4 2014 and has held it in 18 quarters since.
- OppenheimerFunds's Eli Lilly position peaked at $60.1M in Q3 2015.
- 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.